Immunohistochemical Analysis of Cerebrospinal Fluid in Cancer Patients
Author Information
Author(s): A. Hovestadt, S.C. Henzen-Logmans, Ch.J. Vecht
Primary Institution: Dr Daniel Den Hoed Cancer Centre
Hypothesis
What is the sensitivity and specificity of immunohistochemical analysis compared to standard cytological examination in patients with cancer and possible leptomeningeal disease?
Conclusion
Immunohistochemistry should not be used as a screening test for leptomeningeal disease in cancer patients.
Supporting Evidence
- The sensitivity of immunohistochemical analysis was found to be 0.54 and specificity 0.98.
- Only one patient had a positive immunohistochemistry and a negative cytology.
- The gain of adding immunohistochemistry to cytology is nearly 8%.
Takeaway
Doctors looked at fluid from the spine of cancer patients to see if a special test could find cancer cells better than the usual test, but it didn't help much.
Methodology
The study evaluated 135 CSF samples from 68 patients using cytological and immunohistochemical analysis.
Limitations
The study only evaluated the first CSF sample from each patient, which may not represent the overall condition.
Participant Demographics
Patients included those with solid tumors and hematological malignancies.
Statistical Information
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website